Overview

A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to collect additional pharmacokinetic and safety data of voriconazole in immunocompromised adolescents receiving intravenous and oral voriconazole. This will help establish voriconazole dosing recommendations for adolescents.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole